Regulatory interactions between daptomycin‐ and bacitracin‐responsive pathways coordinate the cell envelope antibiotic resistance response of Enterococcus faecalis

Sali M. Morris,Laura Wiens,Olivia Rose,Georg Fritz,Tim Rogers,Susanne Gebhard
DOI: https://doi.org/10.1111/mmi.15264
2024-04-24
Molecular Microbiology
Abstract:This study explored a regulatory network controlling resistance against daptomycin and bacitracin in Enterococcus faecalis. We show that resistance gene expression for both antibiotics is controlled by two regulatory systems, LiaFSR and SapRS, working in sequence and together processing two stimuli. Convergence of this network on the dltXABCD target operon, known to be associated with daptomycin resistance, may explain why clinical resistance can emerge via regulatory mutations. Enterococcal infections frequently show high levels of antibiotic resistance, including to cell envelope‐acting antibiotics like daptomycin (DAP). While we have a good understanding of the resistance mechanisms, less is known about the control of such resistance genes in enterococci. Previous work unveiled a bacitracin resistance network, comprised of the sensory ABC transporter SapAB, the two‐component system (TCS) SapRS and the resistance ABC transporter RapAB. Interestingly, components of this system have recently been implicated in DAP resistance, a role usually regulated by the TCS LiaFSR. To better understand the regulation of DAP resistance and how this relates to mutations observed in DAP‐resistant clinical isolates of enterococci, we here explored the interplay between these two regulatory pathways. Our results show that SapR regulates an additional resistance operon, dltXABCD, a known DAP resistance determinant, and show that LiaFSR regulates the expression of sapRS. This regulatory structure places SapRS‐target genes under dual control, where expression is directly controlled by SapRS, which itself is up‐regulated through LiaFSR. The network structure described here shows how Enterococcus faecalis coordinates its response to cell envelope attack and can explain why clinical DAP resistance often emerges via mutations in regulatory components.
microbiology,biochemistry & molecular biology
What problem does this paper attempt to address?